Blue Cross | Blue Shield | Blue Care Network of Michigan The Record

Stethoscope with RX papers

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article
March 2020

Starting May 1, we’ll no longer cover Soma products

Our goal at Blue Cross Blue Shield of Michigan and Blue Care Network is to provide our members with safe, high quality, cost-effective prescription drugs. To do this, we’re making some changes to drugs we cover.

Starting May 1, 2020, Blue Cross and BCN will no longer cover the following Soma® products:

  • Soma and its generic, carisoprodol
  • Soma compound and its generic, carisoprodol with aspirin
  • Soma compound with codeine and its generic

If members fill a prescription for one of these drugs on or after May 1, 2020, they’ll be responsible for the full cost. We’ll cover the following alternatives that have similar effectiveness, quality and safety:

  • Flexeril® (cyclobenzaprine)
  • Norflex® (orphenadrine)
  • Robaxin® (methocarbamol)
  • Parafon Forte DSC (chlorzoxazone)
  • Zanaflex® (tizanidine)

We’ll mail notification letters to members about this change. The letters will also encourage members to talk to their doctors about getting a prescription for one of the covered alternatives.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2019 American Medical Association. All rights reserved.
Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and
independent licensees of the Blue Cross and Blue Shield Association.